ATNM
Price
$1.58
Change
-$0.11 (-6.51%)
Updated
Sep 5 closing price
Capitalization
49.29M
79 days until earnings call
IPSC
Price
$0.50
Change
+$0.02 (+4.17%)
Updated
Sep 5 closing price
Capitalization
43.6M
61 days until earnings call
Interact to see
Advertisement

ATNM vs IPSC

Header iconATNM vs IPSC Comparison
Open Charts ATNM vs IPSCBanner chart's image
Actinium Pharmaceuticals
Price$1.58
Change-$0.11 (-6.51%)
Volume$391.58K
Capitalization49.29M
Century Therapeutics
Price$0.50
Change+$0.02 (+4.17%)
Volume$548.02K
Capitalization43.6M
ATNM vs IPSC Comparison Chart in %
Loading...
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATNM vs. IPSC commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATNM is a Hold and IPSC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ATNM: $1.58 vs. IPSC: $0.50)
Brand notoriety: ATNM and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATNM: 202% vs. IPSC: 65%
Market capitalization -- ATNM: $49.29M vs. IPSC: $43.6M
ATNM [@Biotechnology] is valued at $49.29M. IPSC’s [@Biotechnology] market capitalization is $43.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATNM’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • ATNM’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATNM and IPSC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATNM’s TA Score shows that 3 TA indicator(s) are bullish while IPSC’s TA Score has 3 bullish TA indicator(s).

  • ATNM’s TA Score: 3 bullish, 6 bearish.
  • IPSC’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than ATNM.

Price Growth

ATNM (@Biotechnology) experienced а -11.24% price change this week, while IPSC (@Biotechnology) price change was +2.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.52%, and the average quarterly price growth was +33.01%.

Reported Earning Dates

ATNM is expected to report earnings on Nov 24, 2025.

IPSC is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATNM($49.3M) has a higher market cap than IPSC($43.6M). ATNM YTD gains are higher at: 25.397 vs. IPSC (-50.030). IPSC has higher annual earnings (EBITDA): -6.16M vs. ATNM (-43.43M). IPSC has more cash in the bank: 156M vs. ATNM (59.9M). ATNM has less debt than IPSC: ATNM (1.29M) vs IPSC (51.5M). IPSC has higher revenues than ATNM: IPSC (114M) vs ATNM (0).
ATNMIPSCATNM / IPSC
Capitalization49.3M43.6M113%
EBITDA-43.43M-6.16M705%
Gain YTD25.397-50.030-51%
P/E RatioN/AN/A-
Revenue0114M-
Total Cash59.9M156M38%
Total Debt1.29M51.5M3%
FUNDAMENTALS RATINGS
ATNM: Fundamental Ratings
ATNM
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATNMIPSC
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TE1.980.13
+7.03%
T1 Energy Inc.
MDBPF3.17N/A
N/A
MEDIBANK PRIVATE LTD
MNHFF72.00N/A
N/A
Mayr-Melnhof Karton AG
VVPR4.80-0.02
-0.31%
VivoPower International PLC
ZMDTF1.52-0.01
-0.65%
Zoomd Technologies Ltd.

ATNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATNM has been loosely correlated with IPSC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATNM jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATNM
1D Price
Change %
ATNM100%
-6.51%
IPSC - ATNM
48%
Loosely correlated
+5.41%
CRBU - ATNM
45%
Loosely correlated
+1.08%
RXRX - ATNM
43%
Loosely correlated
+1.99%
ADVM - ATNM
42%
Loosely correlated
+11.04%
HLVX - ATNM
40%
Loosely correlated
N/A
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+5.41%
CRSP - IPSC
56%
Loosely correlated
+4.02%
IMNM - IPSC
52%
Loosely correlated
+7.35%
CABA - IPSC
52%
Loosely correlated
+10.39%
NTLA - IPSC
49%
Loosely correlated
+3.79%
FATE - IPSC
49%
Loosely correlated
+3.81%
More